Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Skeletal Muscle Relaxants: Therapeutic Uses01:31

Skeletal Muscle Relaxants: Therapeutic Uses

1.2K
Skeletal muscle relaxants are used to relax muscle tone and alleviate painful muscle contractions. However, the choice of skeletal muscle relaxants depends on the duration of the surgical procedure in order to minimize potential side effects. Skeletal muscle relaxants like neuromuscular blocking agents [NMBAs] are commonly employed as adjuvants alongside general anesthetics in clinical settings. NMBAs are also used to maintain controlled ventilation during surgery of the larynx or pharynx...
1.2K
Directly Acting Muscle Relaxants: Dantrolene and Botulinum Toxin01:26

Directly Acting Muscle Relaxants: Dantrolene and Botulinum Toxin

2.2K
Directly acting muscle relaxants like dantrolene and botulinum toxin (BoNT) have distinct mechanisms and applications. Dantrolene, a hydantoin derivative, acts on the ryanodine receptor (RYR1) in skeletal muscle cells. RYR1 are calcium channels present at the sarcoplasmic reticulum membrane. In response to excitation, they release calcium ions from the sarcoplasmic reticulum to the cytosol. Calcium promotes actin-myosin-mediated contraction of muscles.
The binding of dantrolene to the RYR1...
2.2K
Direct-Acting Cholinergic Agonists: Therapeutic Uses01:11

Direct-Acting Cholinergic Agonists: Therapeutic Uses

1.9K
Direct-acting cholinergic agonists have many therapeutic uses in various medical fields. Choline esters, including acetylcholine, have limited clinical utility due to their non-selectivity and short duration of action. Still, acetylcholine and carbachol are applied topically during ophthalmologic surgery to induce miosis. Pilocarpine, a muscarinic and ganglionic stimulator, effectively treats open-angle glaucoma and alleviates xerostomia and dry mouth caused by radiotherapy or Sjögren...
1.9K
Depolarizing Blockers: Pharmocokinetics01:19

Depolarizing Blockers: Pharmocokinetics

784
Depolarizing blockers are administered through intravenous injection. Succinylcholine is the most common choice of depolarizing blockers in emergency clinical practices. Although they have a rapid onset, they readily diffuse away from the motor end plate into the extracellular fluid. They are metabolized by enzymes such as liver butyrylcholinesterase and plasma pseudocholinesterases. This produces a short duration of action, typically 5-10 minutes long, unlike nondepolarizing blockers, which...
784
Indirect-Acting Cholinergic Agonists: Pharmacological Actions01:30

Indirect-Acting Cholinergic Agonists: Pharmacological Actions

1.8K
Indirect-acting cholinergic agonists, also known as anticholinesterases, exert their pharmacological effects by enhancing cholinergic transmission in various body parts, including the neuromuscular junction, autonomic cholinergic synapses, and the brain.
At the neuromuscular junction, these agents work by inhibiting the breakdown of acetylcholine, allowing it to remain bound to the receptor and bind to nearby receptors. This process leads to repetitive firing of the endplate, causing muscle...
1.8K
Depolarizing Blockers: Mechanism of Action01:28

Depolarizing Blockers: Mechanism of Action

3.5K
Depolarizing blockers act on skeletal muscle fibers' membranes and induce their depolarization. Most depolarizing blockers have two quaternary N+ atoms that bind the nicotinic acetylcholine receptors and cause neuromuscular blockade within minutes.
Succinylcholine is the most commonly used depolarizing blocker. Chemically, it constitutes two molecules of acetylcholine joined together by an acetate methyl group. They act on the receptors in the same way as acetylcholine. Because...
3.5K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Regulation of Amino Acid Transporters by Cell Surface Receptors.

Antioxidants (Basel, Switzerland)·2026
Same author

Sex-related susceptibility to pulmonary fibrosis development in mice.

British journal of pharmacology·2026
Same author

LAT1/SLC7A5-mediated amino acid uptake is regulated by redox signals triggered by formyl-peptide receptor 2.

The FEBS journal·2025
Same author

Detection of biosynthetic citric acid and sugar addition in Italian tomato passata using liquid chromatography-combustion-isotope ratio mass spectrometry.

Food chemistry·2025
Same author

Multimodality Imaging in Eosinophilic Myocarditis: A Rare Cause of Heart Failure.

Journal of cardiovascular development and disease·2025
Same author

Unveiling the biological effects of DNA G-quadruplex ligands through multi-omics data integration.

International journal of biological macromolecules·2025

Related Experiment Video

Updated: May 6, 2026

Ultrasound-guided Botulinum Toxin-A Injections: A Method of Treating Sialorrhea
07:05

Ultrasound-guided Botulinum Toxin-A Injections: A Method of Treating Sialorrhea

Published on: November 9, 2016

24.5K

Pneumatic dilation and botulinum toxin: when and why?

Rosamaria Bozzi, Vincenzo Di Martino, Antonio Inzirillo

    Annali Italiani Di Chirurgia
    |October 22, 2013
    PubMed
    Summary

    Pneumatic dilation and botulinum toxin are endoscopic treatments for achalasia. Botulinum toxin offers temporary relief, while pneumatic dilation provides a more durable, non-surgical option for managing this esophageal condition.

    More Related Videos

    Isolation and Quantification of Botulinum Neurotoxin From Complex Matrices Using the BoTest Matrix Assays
    12:25

    Isolation and Quantification of Botulinum Neurotoxin From Complex Matrices Using the BoTest Matrix Assays

    Published on: March 3, 2014

    15.6K
    Subcutaneous Neurotrophin 4 Infusion Using Osmotic Pumps or Direct Muscular Injection Enhances Aging Rat Laryngeal Muscles
    05:50

    Subcutaneous Neurotrophin 4 Infusion Using Osmotic Pumps or Direct Muscular Injection Enhances Aging Rat Laryngeal Muscles

    Published on: June 13, 2017

    8.0K

    Related Experiment Videos

    Last Updated: May 6, 2026

    Ultrasound-guided Botulinum Toxin-A Injections: A Method of Treating Sialorrhea
    07:05

    Ultrasound-guided Botulinum Toxin-A Injections: A Method of Treating Sialorrhea

    Published on: November 9, 2016

    24.5K
    Isolation and Quantification of Botulinum Neurotoxin From Complex Matrices Using the BoTest Matrix Assays
    12:25

    Isolation and Quantification of Botulinum Neurotoxin From Complex Matrices Using the BoTest Matrix Assays

    Published on: March 3, 2014

    15.6K
    Subcutaneous Neurotrophin 4 Infusion Using Osmotic Pumps or Direct Muscular Injection Enhances Aging Rat Laryngeal Muscles
    05:50

    Subcutaneous Neurotrophin 4 Infusion Using Osmotic Pumps or Direct Muscular Injection Enhances Aging Rat Laryngeal Muscles

    Published on: June 13, 2017

    8.0K

    Area of Science:

    • Gastroenterology
    • Endoscopic Procedures
    • Esophageal Motility Disorders

    Background:

    • Achalasia is a primary esophageal motility disorder characterized by impaired relaxation of the lower esophageal sphincter (LES).
    • Endoscopic interventions, including botulinum toxin (BT) injection and pneumatic dilation (PD), are primary treatment options for achalasia.
    • Understanding the nuances of each treatment is crucial for effective patient management.

    Purpose of the Study:

    • To compare the efficacy and indications for botulinum toxin (BT) injection and pneumatic dilation (PD) in treating achalasia.
    • To delineate the mechanisms of action, benefits, and limitations of each endoscopic approach.
    • To provide guidance on selecting the appropriate treatment based on patient characteristics and procedural outcomes.

    Main Methods:

    • Review of the mechanisms of action for BT injection (cholinergic blockade) and PD (LES myotomy).
    • Analysis of reported outcomes, including efficacy, duration of response, and safety profiles of both procedures.
    • Discussion of patient selection criteria, with BT often favored for elderly or comorbid patients and PD for those seeking more durable relief.

    Main Results:

    • Botulinum toxin provides temporary reduction in LES pressure but exhibits variable response duration and efficacy that may decrease over time.
    • Pneumatic dilation is considered a highly effective non-surgical treatment, aiming to disrupt LES muscle fibers for sustained relief.
    • The choice between PD and surgical myotomy often depends on local expertise and procedural availability.

    Conclusions:

    • Botulinum toxin is a safe option for achalasia patients unsuitable for invasive procedures, offering initial symptom improvement.
    • Pneumatic dilation represents a more definitive non-surgical endoscopic treatment for achalasia, with outcomes influenced by procedural technique.
    • Ongoing research explores alternative endoscopic treatments like submucosal myotomy and self-expanding metallic stents for achalasia management.